Clinical Trials on Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD) in Switzerland

Total 1 results

AstraZeneca

Completed

Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention (PANDORA)

Peripheral Arterial Disease (PAD) | Moderate Risk for Cardiovascular Disease (CVD)

France, Netherlands, Switzerland, Greece, Belgium, Italy

3

Subscribe